NCT03093116 2026-05-27TRIDENT-1Turning Point Therapeutics, Inc.Phase 1/2 Recruiting500 enrolled 2 FDA
NCT05655494 2026-05-08A Multilevel Approach to Connecting Underrepresented Populations to Clinical TrialsUniversity of FloridaRecruiting350 enrolled